Intrusion detection has been a key topic in the field of cyber security, and the common network threats nowadays have the characteristics of varieties and variation. Considering the serious imbalance of intrusion detection datasets will result in low classification performance on attack behaviors of small sample size and difficulty to detect network attacks accurately and efficiently, using Adaptive Synthetic Sampling (ADASYN) method to balance datasets was proposed in this paper. In addition, Random Forest algorithm was used to train intrusion detection classifiers.Through the comparative experiment of Intrusion detection on CICIDS 2017 dataset, it is found that ADASYN with Random Forest performs better. Based on the experimental results, the improvement of precision, recall, F1 scores and AUC values after ADASYN is then analyzed. Experiments show that the proposed method can be applied to intrusion detection with large data, and can effectively improve the classification accuracy of network attack behaviors.Compared with traditional machine learning models, it has better performance, generalization ability and robustness.
With the widespread success of deep learning in biomedical image segmentation, domain shift becomes a critical and challenging problem, as the gap between two domains can severely affect model performance when deployed to unseen data with heterogeneous features. To alleviate this problem, we present a novel unsupervised domain adaptation network, for generalizing models learned from the labeled source domain to the unlabeled target domain for cross-modality biomedical image segmentation. Specifically, our approach consists of two key modules, a conditional domain discriminator (CDD) and a category-centric prototype aligner (CCPA). The CDD, extended from conditional domain adversarial networks in classifier tasks, is effective and robust in handling complex cross-modality biomedical images. The CCPA, improved from the graph-induced prototype alignment mechanism in cross-domain object detection, can exploit precise instance-level features through an elaborate prototype representation. In addition, it can address the negative effect of class imbalance via entropy-based loss. Extensive experiments on a public benchmark for the cardiac substructure segmentation task demonstrate that our method significantly improves performance on the target domain. INDEX TERMS Biomedical image segmentation, cross-modality learning, unsupervised domain adaptation, category-centric prototype aligner.
With the widespread success of deep learning in biomedical image segmentation, domain shift becomes a critical and challenging problem, as the gap between two domains can severely affect model performance when deployed to unseen data with heterogeneous features. To alleviate this problem, we present a novel unsupervised domain adaptation network, for generalizing models learned from the labeled source domain to the unlabeled target domain for cross-modality biomedical image segmentation. Specifically, our approach consists of two key modules, a conditional domain discriminator (CDD) and a category-centric prototype aligner (CCPA). The CDD, extended from conditional domain adversarial networks in classifier tasks, is effective and robust in handling complex cross-modality biomedical images. The CCPA, improved from the graph-induced prototype alignment mechanism in cross-domain object detection, can exploit precise instance-level features through an elaborate prototype representation. In addition, it can address the negative effect of class imbalance via entropy-based loss. Extensive experiments on a public benchmark for the cardiac substructure segmentation task demonstrate that our method significantly improves performance on the target domain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.